The Nevada National Board Professional Learning Institute | Rowe | Activity http://www.nationalboardinstitute.com/members/brickwalrus1/activity/ Activity feed for Rowe. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 01158c90e5ba8abe370ca1bf46e3aae8 Rowe posted an update: L-Carnosine is an amino acid that acts as an anti-oxidant, […] http://www.nationalboardinstitute.com/activity/p/41002/ Fri, 07 Feb 2025 10:34:19 -0800 L-Carnosine is an amino acid that acts as an anti-oxidant, anti-toxic and neuroprotective agent. There is a paucity of data about the effectiveness of L-Carnosine in the management of autism spectrum disorder (ASD) in children. This study aimed at investigating the effectiveness of L-Carnosine as adjunctive therapy in the management of ASD. This…[Read more]

]]> 0 dda55079dc759e5a51724e2fe4f74d2a Rowe posted an update: All rights reserved.The search for new dyes to be used as […] http://www.nationalboardinstitute.com/activity/p/39087/ Wed, 05 Feb 2025 10:28:00 -0800 All rights reserved.The search for new dyes to be used as photosensitizers in photodynamic therapy (PDT) is a field of great interest from both experimental and theoretical viewpoints. In this study, the main photophysical properties (excitation energies, singlet-triplet energy gap, and spin orbit coupling matrix elements) of some unsubstituted…[Read more]

]]> 0 4a267cf70dfabc3dfa3de7a0bad0034b Rowe posted an update: Mental health consequences of the COVID-19 pandemic have […] http://www.nationalboardinstitute.com/activity/p/35622/ Sat, 01 Feb 2025 10:19:58 -0800 Mental health consequences of the COVID-19 pandemic have been observed. Psychiatric symptoms in people living with HIV, and their relationship to physical symptomatology and prior psychopathology, are not yet reported.

An HIV cohort sheltering-in-place in New York City.

Forty-nine participants in a longitudinal study were contacted…[Read more]

]]> 0 b8dff268311915d54135a32b3c00f794 Rowe posted an update: Human epidermal growth factor receptor-2 (HER-2) tyrosine […] http://www.nationalboardinstitute.com/activity/p/33142/ Thu, 30 Jan 2025 07:22:02 -0800 Human epidermal growth factor receptor-2 (HER-2) tyrosine kinase inhibitors (TKI) is the targeted drug of HER-2-positive breast cancer. Lapatinib, pyrotinib and neratinib, as ErbB family TKIs, have been approved by National Medical Products Administration and applied in the treatment of HER-2 positive breast cancer in China. The most common…[Read more]

]]> 0 94fa8c4eeaf0179c5daf1b30135c070f Rowe became a registered member http://www.nationalboardinstitute.com/activity/p/28706/ Tue, 28 Jan 2025 11:38:35 -0800 0